Despite the availability of safe and effective anti-osteoporosis treatments, osteoporosis
continues to be undertreated. The increase in fragility fractures, which is the main clinical …

Identification of patients at risk for fragility fractures is the first important step in the
management of osteoporosis. Bisphosphonates have been the mainstay of treatment for …

In patients with osteoporosis and severely reduced bone mass and/or recurring fractures,
antiresorptive therapy may not be the optimal first-line treatment. Two recent clinical trials …

Background: Osteoporosis is a skeletal disorder characterized by compromised bone
strength resulting in a predisposition to fracture. Osteoporosis-related fractures can lead to …

Osteoporotic fractures are a worldwide problem that increase mortality of elderly patients
leaving a high cost to the world economy. In addition to exercise and supplementary …

Osteoporosis is a common chronic condition that markedly increases the risk of fractures.
Osteoporotic-related fractures increase morbidity and mortality and impair quality of life …

In the past three decades, clinicians treating osteoporosis have seen the disease change
from being a debilitating chronic disease with few treatment options and little chance of real …

Osteoporosis is a systemic skeletal disease characterized by reduced bone mass and
deterioration of bone tissue microarchitecture leading to an increased risk of fractures …

Efficient therapies are available for the treatment of osteoporosis. Anti‐resorptive therapies,
including bisphosphonates and denosumab, increase bone mineral density (BMD) and …

Background A fracture that occurs in people with low bone mass in the setting of minimal
trauma—such as a fall from standing height—meets the criteria for the clinical diagnosis of …